Episurf Medical AB's 2023 annual report is now available

Episurf Medical's annual report for 2023 is available as of today at the company's website, www.episurf.com. 

Episurf Medical has of environmental and cost reasons chosen not to print the annual report. A printed version of the annual report will be distributed to shareholders and others who made such request. The annual report can also be ordered from Episurf Medical on the following address: Episurf Medical AB, Karlavägen 60, 114 49 Stockholm, Sweden or by email: [e-mail].

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:[phone]
Email: [e-mail]

Veronica Wallin, CFO, Episurf Medical
Tel:[phone]
Email: [e-mail]

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.

This information is information that Episurf Medical AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 21.15 CET on 7 March 2024.

https://news.cision.com/episurf/r/episurf-medical-ab-s-2023-annual-report-is-now-available,c3942687

https://mb.cision.com/Main/14691/3942687/2656150.pdf

https://mb.cision.com/Main/14691/3942687/2656151.zip

(c) 2024 Cision. All rights reserved., source Press Releases - English